000 01381 a2200421 4500
005 20250510211042.0
264 0 _c19781027
008 197810s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(78)92217-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLamon, J M
245 0 0 _aPrevention of acute porphyric attacks by intravenous haematin.
_h[electronic resource]
260 _bLancet (London, England)
_cSep 1978
300 _a492-4 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAcute Disease
650 0 4 _aAdult
650 0 4 _aAminolevulinic Acid
_xurine
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCircadian Rhythm
_xdrug effects
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHeme
_xanalogs & derivatives
650 0 4 _aHemin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInfusions, Parenteral
650 0 4 _aMenstruation
650 0 4 _aPorphobilinogen
_xurine
650 0 4 _aPorphyrias
_xphysiopathology
650 0 4 _aPulse
_xdrug effects
650 0 4 _aRemission, Spontaneous
700 1 _aFrykholm, B C
700 1 _aBennett, M
700 1 _aTschudy, D P
773 0 _tLancet (London, England)
_gvol. 2
_gno. 8088
_gp. 492-4
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(78)92217-1
_zAvailable from publisher's website
999 _c77922
_d77922